Cargando…
DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis
Decoy receptor 3 (DcR3) is abnormally up-regulated in many cancer cells. It may help cancer cells to escape from immune surveillance and establish metastatic lesions. However, whether DcR3 can be used as a biomarker for the diagnosis of cancer metastasis is unclear. In this study, sera from healthy...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746094/ https://www.ncbi.nlm.nih.gov/pubmed/29296192 http://dx.doi.org/10.18632/oncotarget.22544 |